Lili Chen

1.1k total citations
35 papers, 862 citations indexed

About

Lili Chen is a scholar working on Oncology, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Lili Chen has authored 35 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Molecular Biology and 10 papers in Computational Theory and Mathematics. Recurrent topics in Lili Chen's work include Computational Drug Discovery Methods (10 papers), Drug Transport and Resistance Mechanisms (7 papers) and Pharmacological Effects of Natural Compounds (6 papers). Lili Chen is often cited by papers focused on Computational Drug Discovery Methods (10 papers), Drug Transport and Resistance Mechanisms (7 papers) and Pharmacological Effects of Natural Compounds (6 papers). Lili Chen collaborates with scholars based in China, United States and Sweden. Lili Chen's co-authors include Hongzhuan Chen, Hai‐Liang Zhu, Hairong Wang, Ya‐Lin Qi, Xin Luan, Mengge Wang, Yongfang Zhao, Shengyu Yang, Yongtao Duan and Jianrong Xu and has published in prestigious journals such as Chemical Society Reviews, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Lili Chen

32 papers receiving 850 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lili Chen China 15 365 162 145 145 124 35 862
Nan Ma China 20 825 2.3× 287 1.8× 99 0.7× 180 1.2× 112 0.9× 90 1.7k
Yan Guan China 16 598 1.6× 94 0.6× 166 1.1× 73 0.5× 52 0.4× 26 1.0k
Ren-ai Xu China 16 258 0.7× 146 0.9× 37 0.3× 265 1.8× 49 0.4× 93 878
Abhay T. Sangamwar India 19 385 1.1× 163 1.0× 188 1.3× 121 0.8× 20 0.2× 65 875
Huy Truong Nguyen Vietnam 14 401 1.1× 60 0.4× 154 1.1× 92 0.6× 84 0.7× 58 830
Bianca M. Liederer United States 20 547 1.5× 370 2.3× 119 0.8× 125 0.9× 21 0.2× 44 1.3k
Mallika Alvala India 25 766 2.1× 146 0.9× 128 0.9× 88 0.6× 34 0.3× 68 1.6k
Mahmoud A. El Hassab Egypt 21 512 1.4× 107 0.7× 200 1.4× 103 0.7× 43 0.3× 72 1.3k
Chun‐Zhi Ai China 19 472 1.3× 125 0.8× 127 0.9× 256 1.8× 59 0.5× 46 889

Countries citing papers authored by Lili Chen

Since Specialization
Citations

This map shows the geographic impact of Lili Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lili Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lili Chen more than expected).

Fields of papers citing papers by Lili Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lili Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lili Chen. The network helps show where Lili Chen may publish in the future.

Co-authorship network of co-authors of Lili Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Lili Chen. A scholar is included among the top collaborators of Lili Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lili Chen. Lili Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Jiani, Yan Tang, Hongtao Li, et al.. (2025). Identifying Exifone as a Dual-Target Agent Targeting Both SARS-CoV-2 3CL Protease and the ACE2/S-RBD Interaction Among Clinical Polyphenolic Compounds. International Journal of Molecular Sciences. 26(5). 2243–2243. 1 indexed citations
2.
Lu, Jiani, Yan Tang, Hongtao Li, et al.. (2025). Exploring anti-SARS-CoV-2 natural products: dual-viral target inhibition by delphinidin and the anti-coronaviral efficacy of deapio platycodin D. Natural Products and Bioprospecting. 15(1). 39–39.
3.
Li, Hongtao, Jinfeng Liu, Ying Wang, et al.. (2024). Methyl rosmarinate is an allosteric inhibitor of SARS-CoV-2 3 CL protease as a potential candidate against SARS-cov-2 infection. Antiviral Research. 224. 105841–105841. 4 indexed citations
4.
He, Yingying, et al.. (2024). Efficient synthesis of bioactive isoindolinone derivatives containing continuous quaternary carbons by intermolecular OH transfer. New Journal of Chemistry. 48(17). 7754–7760. 3 indexed citations
5.
Chen, Xuwen, Hongtao Li, Meiting Wang, et al.. (2024). Discovery of Chalcone Derivatives as Bifunctional Molecules with Anti-SARS-CoV-2 and Anti-inflammatory Activities. Journal of Natural Products. 87(12). 2680–2694. 2 indexed citations
6.
Lu, Jiani, et al.. (2024). Promising natural products targeting protein tyrosine phosphatase SHP2 for cancer therapy. Phytotherapy Research. 39(4). 1735–1757.
7.
Chen, Xuwen, et al.. (2024). Discovery of potent thiazolidin-4-one sulfone derivatives for inhibition of proliferation of osteosarcoma in vitro and in vivo. European Journal of Medicinal Chemistry. 266. 116082–116082. 3 indexed citations
8.
Lu, Jiani, et al.. (2024). Interferon-I modulation and natural products: Unraveling mechanisms and therapeutic potential in severe COVID-19. Cytokine & Growth Factor Reviews. 82. 18–30. 4 indexed citations
9.
Lu, Jiani, Hongtao Li, Xuwen Chen, et al.. (2024). Exploring bifunctional molecules for anti-SARS-CoV-2 and anti-inflammatory activity through structure-based virtual screening, SAR investigation, and biological evaluation. International Journal of Biological Macromolecules. 287. 138529–138529. 1 indexed citations
10.
Liu, Tong, et al.. (2024). Tuina Inhibits Chondrocyte Apoptosis by Regulating the FAK/PI3K/Akt Pathway in Rabbits with IVDD. Combinatorial Chemistry & High Throughput Screening. 28(10). 1746–1753. 2 indexed citations
11.
Chen, Xuwen, Hongtao Li, Danmei Yu, et al.. (2023). Danshensu inhibits SARS-CoV-2 by targeting its main protease as a specific covalent inhibitor and discovery of bifunctional compounds eliciting antiviral and anti-inflammatory activity. International Journal of Biological Macromolecules. 257(Pt 2). 128623–128623. 14 indexed citations
12.
Wang, Mengge, Lijun Zhang, Hong Zhang, et al.. (2022). Dihydrotanshinone I Inhibits the Proliferation and Growth of Oxaliplatin-Resistant Human HCT116 Colorectal Cancer Cells. Molecules. 27(22). 7774–7774. 14 indexed citations
13.
Qi, Ya‐Lin, Hairong Wang, Lili Chen, et al.. (2022). Multifunctional Fluorescent Probe for Simultaneously Detecting Microviscosity, Micropolarity, and Carboxylesterases and Its Application in Bioimaging. Analytical Chemistry. 94(11). 4594–4601. 52 indexed citations
14.
Zhu, Guanghao, Mengge Wang, Xiaoyi Gong, et al.. (2022). Discovery and mechanism of action of Thonzonium bromide from an FDA-approved drug library with potent and broad-spectrum inhibitory activity against main proteases of human coronaviruses. Bioorganic Chemistry. 130. 106264–106264. 11 indexed citations
15.
Jin, Jinmei, Pei An, Lijun Zhang, et al.. (2021). The Cyr61 Is a Potential Target for Rotundifuran, a Natural Labdane‐Type Diterpene from Vitex trifolia L., to Trigger Apoptosis of Cervical Cancer Cells. Oxidative Medicine and Cellular Longevity. 2021(1). 6677687–6677687. 19 indexed citations
16.
Yin, Yiming, Mengge Wang, Wenjie Gu, & Lili Chen. (2021). Intestine-specific FXR agonists as potential therapeutic agents for colorectal cancer. Biochemical Pharmacology. 186. 114430–114430. 20 indexed citations
17.
Yang, Hui, et al.. (2021). Clinical significance of mucinous component in colorectal adenocarcinoma: a propensity score-matched study. BMC Cancer. 21(1). 1286–1286. 11 indexed citations
18.
Chen, Lili, Xia Huang, Jianrong Xu, et al.. (2020). Combating COVID-19 with integrated traditional Chinese and Western medicine in China. Acta Pharmaceutica Sinica B. 10(7). 1149–1162. 128 indexed citations
19.
Jin, Jinmei, Ye Wu, Yiwen Shen, et al.. (2020). The peptide PROTAC modality: a novel strategy for targeted protein ubiquitination. Theranostics. 10(22). 10141–10153. 100 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nan Ma Breakdown of academic impact, for papers by Yan Guan Breakdown of academic impact, for papers by Ren-ai Xu Breakdown of academic impact, for papers by Abhay T. Sangamwar Breakdown of academic impact, for papers by Huy Truong Nguyen Breakdown of academic impact, for papers by Bianca M. Liederer Breakdown of academic impact, for papers by Mallika Alvala Breakdown of academic impact, for papers by Mahmoud A. El Hassab Breakdown of academic impact, for papers by Chun‐Zhi Ai
Rankless by CCL
2026